Smoking Cessation – Data, Analysis & Forecasts to 2023

The report “Smoking Cessation – Data, Analysis & Forecasts to 2023 ″ by GMR Data Ltd is now available at RnRMarketResearch.com. Contact sales@rnrmarketresearch.com with Smoking Cessation – Data, Analysis & Forecasts to 2023 in subject line and your contact details to purchase this report or get your questions answered.

The collection of ‘Therapeutics’ market research reports has a new addition of “Smoking Cessation – Data, Analysis & Forecasts to 2023” on RnRMarketResearch.com. The report outlines key drivers and restraints of the market in all key global geographies.

Key drivers of the global smoking cessation market include;

§  Increased health care / health education in many geographies

§  Adoption of smoking cessation products onto health insurance policies

§  Increasing number of smoking cessation products emerging onto the market

§  Emergence of e-cigarettes onto the global market

§  Over 1bn smokers world wide

This report quantifies the market, in terms of each key geography; explaining which direction each key market will head across the next ten years, and why, with detailed financial forecasts. The report contains over 100 pages as well as 85 charts, graphs and tables detailing the market.

Buy a copy of this report by GMR Data Ltd@    http://www.rnrmarketresearch.com/contacts/purchase?rname=128038 .

This report also includes 3 original, exclusive, interview transcripts with key global pharmaceutical companies;

• Pfizer
• Elder Pharmaceuticals
• GlaxoSmithKline

Purchase this report today to find out where company features in today’s market; find the key brands and products on the market and where they will be sold globally.

Complete report spread across [101] pages available @ http://www.rnrmarketresearch.com/smoking-cessation-data-analysis-forecasts-to-2023-market-report.html . Read more on “Smoking Cessation – Data, Analysis & Forecasts to 2023” report below.

List of Companies

• 22nd Century Group, Inc
• Acrux
• Alcon Inc
• Altria Group Inc
• Alza Corporation
• American Lung Association and Cancer Advocacy Coalition of Canada
• Aradigm Corporation
• Biota Holdings Ltd
• Biota Pharmaceuticals, Inc.
• Birlaveda
• British American Tobacco
• Celtic Pharmaceuticals
• Cipla
• CN Creative
• Cytos Biotechnology
• Elder Pharmaceuticals limited
• EverSmoke Electronic Cigarettes
• Evotec AG
• Extab Corporation
• Frii Inc
• GlaxoSmithKline
• Green Smoke Inc
• Imperial Tobacco
• Independent Pharmaceutica AB
• Institute of Human Behaviour & Allied Sciences
• Invion Limited
• Johnson & Johnson
• KLOX Technologies
• Lorillard Inc
• McNeil
• Nabi Biopharmaceuticals
• NAL Pharmaceuticals
• National Institute on Drug Abuse
• Nicobrand
• Niconovum AB
• NJOY
• Novartis
• Nu Mark LLC
• Perrigo
• Pfizer Inc
• Pure Cigs, LLC
• Reynolds American Inc
• RML Hospital and Chronic Care Foundation
• Sandoz Pharmaceuticals
• Selecta Biosciences, Inc
• Shanghai Johnson & Johnson Pharmaceutical Ltd
• Sopharma
• South Beach Smoke
• Sun Pharma
• Taranabant, Merck & Co
• Teva Pharmaceuticals
• U.S. Preventive Services Task Force
• University of Chicago
• Vapor King
• Volcano Fine Electronic Cigarettes
• Watson Pharmaceuticals
• White Cloud Electronic Cigarettes

For further information on “Smoking Cessation – Data, Analysis & Forecasts to 2023” report OR for any other business research / market intelligence need on the ‘Therapeutics’ market (http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics.), contact sales@rnrmarketresearch.com / Call +1 888 391 5441.